GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » PEG Ratio

Par Drugs and Chemicals (NSE:PAR) PEG Ratio : 0.88 (As of May. 30, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Par Drugs and Chemicals's PE Ratio without NRI is 19.76. Par Drugs and Chemicals's 5-Year EBITDA growth rate is 22.50%. Therefore, Par Drugs and Chemicals's PEG Ratio for today is 0.88.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Par Drugs and Chemicals's PEG Ratio or its related term are showing as below:

NSE:PAR' s PEG Ratio Range Over the Past 10 Years
Min: 0.68   Med: 1.02   Max: 1.24
Current: 0.88


During the past 8 years, Par Drugs and Chemicals's highest PEG Ratio was 1.24. The lowest was 0.68. And the median was 1.02.


NSE:PAR's PEG Ratio is ranked better than
74.8% of 369 companies
in the Drug Manufacturers industry
Industry Median: 1.65 vs NSE:PAR: 0.88

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Par Drugs and Chemicals PEG Ratio Historical Data

The historical data trend for Par Drugs and Chemicals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals PEG Ratio Chart

Par Drugs and Chemicals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PEG Ratio
Get a 7-Day Free Trial - - 1.13 0.67 0.81

Par Drugs and Chemicals Quarterly Data
Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 - - - 0.81

Competitive Comparison of Par Drugs and Chemicals's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Par Drugs and Chemicals's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's PEG Ratio falls into.



Par Drugs and Chemicals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Par Drugs and Chemicals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=19.762308998302/22.50
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Par Drugs and Chemicals  (NSE:PAR) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Par Drugs and Chemicals PEG Ratio Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Par Drugs and Chemicals (NSE:PAR) Business Description

Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage.